Sean A. McCarthy

CEO at CytomX Therapeutics Inc.

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
4 years
Director since
2023

4 years of board service in total across 1 board, counting each seat separately. Longest: CytomX Therapeutics Inc., 3 years.

CytomX Therapeutics Inc. Director ยท CEO
3 years ยท Since 2023

Chief executive roles

Dates unknown

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Mar 17, 2026 CytomX Therapeutics Inc. Open-market sale โˆ’118,969 $6.42 $763,781
Feb 2, 2026 CytomX Therapeutics Inc. Grant or award +210,000 โ€” โ€”
Nov 6, 2025 CytomX Therapeutics Inc. Open-market sale โˆ’101,793 $4.54 $462,140
Jun 16, 2025 CytomX Therapeutics Inc. Open-market sale โˆ’55,511 $2.69 $149,325
Jun 13, 2025 CytomX Therapeutics Inc. Option exercise +150,000 โ€” โ€”
Mar 18, 2025 CytomX Therapeutics Inc. Open-market sale โˆ’37,656 $0.60 $22,594
Feb 4, 2025 CytomX Therapeutics Inc. Grant or award +180,000 โ€” โ€”
Feb 4, 2025 CytomX Therapeutics Inc. Grant or award +195,000 โ€” โ€”
Aug 20, 2024 CytomX Therapeutics Inc. Option exercise +37,500 โ€” โ€”
Aug 20, 2024 CytomX Therapeutics Inc. Open-market sale โˆ’13,898 $1.23 $17,095
Mar 26, 2024 CytomX Therapeutics Inc. Option exercise +109,768 $1.57 $172,336
Mar 19, 2024 CytomX Therapeutics Inc. Open-market sale โˆ’20,223 $2.09 $42,266
Jan 18, 2024 CytomX Therapeutics Inc. Grant or award +90,000 โ€” โ€”
Dec 20, 2023 CytomX Therapeutics Inc. Open-market sale โˆ’13,551 $1.38 $18,700
Dec 17, 2023 CytomX Therapeutics Inc. Option exercise +37,500 โ€” โ€”

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.